Thread regarding Medicines Co. layoffs

Job Cuts Due to Angiomax Going Generic

Many of the jobs lost recently were stricly related to Angiomax going the generic route...

Despite cutting the Angiomax sales team we still do have a large number of openings. On the IDC side of the business going to sell about $20 million this year (Orbactiv/Minocin) but the problem is we are about to spend $45 mil on the on sales and marketing for the two products at issue.

Angiomax sales are dropping and will continue to drop so you are basically cash flow negative and this cannot continue for an extended period of time... Our folks are relatively sharp and most of them can see this, so job cuts and people fleeing the company do not make it easier for us who decided or were chosen to stick around. Good luck in 2016...

| 1245 views | | no replies yet
Post ID: @OP+FR2njaf

There are no replies in this thread yet. Be the first to post a reply below:

Post a reply